These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39196955)

  • 21. Clinical Features and Rate of Infective Endocarditis in Non-Faecalis and Non-faecium Enterococcal Bacteremia.
    Jang HC; Park WB; Kim HB; Kim EC; Oh MD
    Chonnam Med J; 2011 Aug; 47(2):111-5. PubMed ID: 22111070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database.
    Anderson DJ; Olaison L; McDonald JR; Miro JM; Hoen B; Selton-Suty C; Doco-Lecompte T; Abrutyn E; Habib G; Eykyn S; Pappas PA; Fowler VG; Sexton DJ; Almela M; Corey GR; Cabell CH
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):665-70. PubMed ID: 16244853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.
    Pavleas J; Skiada A; Daikos GL; Pefanis A; Giamarellos-Bourboulis E; Kanellakopoulou K; Tsaganos T; Perrea D; Donta I; Karayannakos P; Giamarellou H
    J Chemother; 2008 Apr; 20(2):208-12. PubMed ID: 18467247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
    Peghin M; Russo A; Givone F; Ingani M; Graziano E; Bassetti M
    Infect Dis Ther; 2019 Dec; 8(4):695-702. PubMed ID: 31428940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enterococcal infective endocarditis: description of 12 cases].
    Martínez Odriozola P; Muñoz Sánchez J; Arriola Martínez P; Lizarralde Palacios E; Santamaría Jáuregui JM; Zuazo Meabe J; Cisterna Cáncer R; de la Villa FM
    An Med Interna; 2007 Nov; 24(11):539-42. PubMed ID: 18275263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of referral bias on the apparent clinical spectrum of infective endocarditis.
    Steckelberg JM; Melton LJ; Ilstrup DM; Rouse MS; Wilson WR
    Am J Med; 1990 Jun; 88(6):582-8. PubMed ID: 2346159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
    Sacar M; Sacar S; Cevahir N; Onem G; Teke Z; Asan A; Turgut H; Adali F; Kaleli I; Susam I; Yaylali YT; Baltalarli A
    Tex Heart Inst J; 2010; 37(4):400-4. PubMed ID: 20844611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of infective endocarditis in a large Belgian non-referral hospital.
    Poesen K; Pottel H; Colaert J; De Niel C
    Acta Clin Belg; 2014 Jun; 69(3):183-90. PubMed ID: 24761948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enterococcal endocarditis: clinical features and therapeutic approach].
    Perrone A; Guida G; Morano CM; Papa L; Schiraldi O
    Recenti Prog Med; 1997 Nov; 88(11):507-12. PubMed ID: 9446153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
    Chirouze C; Athan E; Alla F; Chu VH; Ralph Corey G; Selton-Suty C; Erpelding ML; Miro JM; Olaison L; Hoen B;
    Clin Microbiol Infect; 2013 Dec; 19(12):1140-7. PubMed ID: 23517406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. vanA Gene Harboring Enterococcal and Non-enterococcal Isolates Expressing High Level Vancomycin and Teicoplanin Resistance Reservoired in Surface Waters.
    Nakipoğlu M; Yilmaz F; Icgen B
    Bull Environ Contam Toxicol; 2017 May; 98(5):712-719. PubMed ID: 27770152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):27-8. PubMed ID: 23115941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis.
    Duncan CJ; Barr DA; Ho A; Sharp E; Semple L; Seaton RA
    J Antimicrob Chemother; 2013 Jul; 68(7):1650-4. PubMed ID: 23475647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glycopeptide antibiotics in the treatment of infective endocarditis.
    Grüneberg RN; Antunes F; Chambers HF; Garau J; Graninger W; Menichetti F; Peetermans WE; Pittet D; Shah PM; Vogelaers D
    Int J Antimicrob Agents; 1999 Aug; 12(3):191-8. PubMed ID: 10461836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients.
    Leport C; Perronne C; Massip P; Canton P; Leclercq P; Bernard E; Lutun P; Garaud JJ; Vilde JL
    Antimicrob Agents Chemother; 1989 Jun; 33(6):871-6. PubMed ID: 2527483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review.
    Fazili T; Bansal E; Garner D; Gomez M; Stornelli N
    Int J Antimicrob Agents; 2023 Apr; 61(4):106749. PubMed ID: 36758775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterococcal endocarditis management and relapses.
    Garofoli N; Joly V; Le Pluart D; Hobson CA; Beaumont AL; Lariven S; Grall N; Para M; Yazdanpanah Y; Lescure FX; Peiffer-Smadja N; Deconinck L; Thy M
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae033. PubMed ID: 38449516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterococcal Infective Endocarditis - Post discharge treatment with continuous benzylpenicillin and ceftriaxone: A retrospective cohort study.
    Szterenlicht Y; Steinmetz Y; Dadon Z; Wiener-Well Y
    J Infect Chemother; 2024 May; 30(5):429-433. PubMed ID: 38000498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.